@article{3a3532021fa544779a856499f1ed5422,
title = "mTOR inhibitor therapy for patients with carcinoid",
abstract = "Abstract not available",
keywords = "Antineoplastic Agents, Hormonal, Carcinoid Tumor, Female, Humans, Immunosuppressive Agents, Male, Malignant Carcinoid Syndrome, Octreotide, Sirolimus, Antineoplastic Agents, Hormonal, Carcinoid Tumor, Female, Humans, Immunosuppressive Agents, Male, Malignant Carcinoid Syndrome, Octreotide, Sirolimus",
author = "Guido Rindi and M. Caplin",
year = "2011",
doi = "10.1016/S0140-6736(11)61789-3",
language = "English",
volume = "378",
pages = "1978--1980",
journal = "LANCET",
issn = "0923-7577",
publisher = "Editions Scientifique & Medical Elsevier:23 Rue Linois, F 75724 Paris Cedex 15 France:011 33 1 71724646, INTERNET: http://www.elsevier.fr, Fax: 011 33 1 71724664",
}